Oruka Therapeutics

Nasdaq: ORKA · SEC EDGAR filings

Results on file1
Average 24h move+12.99%across 1 result with a complete 24h price
1 resultOruka Therapeutics
Met endpoint

ORKA-001

Phase 2 Plaque Psoriasis

Oruka Therapeutics ORKA

24h stock move +12.99%

For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.